Also trades as: AFP.AX (ASX) · $vol 0M
AFT.NZ NZE
AFT Pharmaceuticals Limited
1W: -0.5%
1M: -0.2%
3M: +17.8%
YTD: +17.5%
1Y: +68.7%
3Y: +23.1%
5Y: -1.6%
NZ$4.30 ($2.40)
-0.07 (-1.60%)
Weekly Expected Move ±2.4%
NZ$4
NZ$4
NZ$4
NZ$4
NZ$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$217M
+27.8% ▲
5Y CAGR: +15.6%
Total Liabilities
$108M
+48.4% ▲
5Y CAGR: +9.5%
Shareholders Equity
$110M
+12.9% ▲
5Y CAGR: +24.7%
Cash & Investments
$10M
-7.8% ▼
5Y CAGR: +26.1%
Total Debt
$54M
+80.4% ▲
5Y CAGR: +5.1%
Net Debt
$44M
+132.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $8M | $5M | $12M | $11M | $10M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $8M | $5M | $12M | $11M | $10M |
| Net Receivables | $30M | $40M | $41M | $43M | $64M |
| Inventory | $34M | $42M | $49M | $48M | $74M |
| Other Current Assets | $100K | $736K | $408K | $192K | -$6M |
| Total Current Assets | $78M | $95M | $106M | $108M | $149M |
| Property, Plant & Equip. | $3M | $3M | $4M | $3M | $3M |
| Goodwill & Intangibles | $38M | $46M | $53M | $58M | $64M |
| Long-Term Investments | -$30M | -$34M | $0 | $0 | $0 |
| Other Non-Current Assets | $30M | $34M | $0 | $0 | $0 |
| Total Non-Current Assets | $44M | $53M | $60M | $61M | $68M |
| Total Assets | $122M | $148M | $165M | $170M | $217M |
| — Liabilities — | |||||
| Accounts Payable | $12M | $22M | $25M | $25M | $30M |
| Short-Term Debt | $4M | $2M | $0 | $1M | $12M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $11M | $13M | $14M | $8M | $14M |
| Total Current Liabilities | $29M | $40M | $46M | $43M | $66M |
| Long-Term Debt | $33M | $32M | $28M | $26M | $39M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $36M | $35M | $31M | $29M | $42M |
| Total Liabilities | $65M | $75M | $77M | $73M | $108M |
| — Equity — | |||||
| Common Stock | $78M | $78M | $78M | $78M | $78M |
| Retained Earnings | -$21M | -$5M | $9M | $20M | $32M |
| Accumulated OCI | $554K | $226K | $298K | -$142K | -$342K |
| Total Stockholders Equity | $57M | $73M | $88M | $98M | $110M |
| Total Liabilities & Equity | $122M | $148M | $165M | $170M | $217M |
| — Key Metrics — | |||||
| Total Debt | $41M | $38M | $32M | $30M | $54M |
| Net Debt | $33M | $33M | $20M | $19M | $44M |
| Total Investments | -$30M | -$34M | $0 | $0 | $0 |